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Introduction {#sec001}
============

Dengue virus (DENV) and Zika virus (ZIKV) are members of *Flaviviridae* and both are transmitted mostly via mosquito bites. It is estimated that around 400 million people are infected with DENV annually\[[@pntd.0006154.ref001]\]. DENV infection symptoms range from mild disease, to dengue fever, dengue hemorrhagic fever, and dengue shock syndromes, which can be fatal in some cases. The mechanisms by which DENV infection causes severe illness are not completely understood. An extensive immune activation, characterized by a cytokine storm, has been described in DENV infection, and host factors are also likely to be involved\[[@pntd.0006154.ref002]\]. Conventional antiviral CD8+ T cells are activated and expanded following DENV infection\[[@pntd.0006154.ref003]\], and have been proposed to be protective by reducing the viral load\[[@pntd.0006154.ref004]\].

Until recently, ZIKV had been understudied because the infection was thought to be associated only with a mild viral illness and of limited geographical distribution. In 2014, the virus suddenly expanded its range dramatically and appeared in the Americas, leading to the most widespread ZIKV outbreak in history. It is now estimated that over 2 billion people are living in regions suitable for ZIKV transmission\[[@pntd.0006154.ref005]\]. ZIKV infection is now linked with cases of Guillain-Barré syndrome\[[@pntd.0006154.ref006]\] and with a plethora of fetal malformations including microcephaly, now called congenital Zika syndrome, following transmission from an infected pregnant woman to her developing fetus\[[@pntd.0006154.ref007]\]. The protective or pathogenic roles of T cells in ZIKV infection remains to be investigated.

Mucosal-associated invariant T (MAIT) cells are a population of innate T cells that represent 1--10% of T cells in the blood of healthy individuals\[[@pntd.0006154.ref008]\]. They express a semi-invariant TCR using Vα7.2 coupled with Jα33 and a limited Vβ repertoire\[[@pntd.0006154.ref009]\]. A small fraction of MAIT cells have been found to express Vα12 or Vα20\[[@pntd.0006154.ref010]\]. Recent studies suggest that the TCR β-chain has some influence on TCR dependent activation of MAIT cells\[[@pntd.0006154.ref011], [@pntd.0006154.ref012]\]. MAIT cells can be identified by the expression of Vα7.2 in combination with CD161 or the IL-18 receptor\[[@pntd.0006154.ref013]\]. They have been shown to recognize microbial vitamin B2 (riboflavin) metabolites presented by the MHC class I-like protein MR1\[[@pntd.0006154.ref014]\]. This allows MAIT cells to respond to a range of bacteria, mycobacteria, and yeasts\[[@pntd.0006154.ref015]\]. MAIT cells can also be activated in a TCR independent way by IL-12 and IL18\[[@pntd.0006154.ref016]\], allowing them to respond to pathogens not producing riboflavin, such as viruses\[[@pntd.0006154.ref017], [@pntd.0006154.ref018]\]. In chronic HIV-1 and HTLV-1 infections, MAIT cells are reduced in number and display impaired functionality in response to bacterial stimulation\[[@pntd.0006154.ref019]--[@pntd.0006154.ref021]\]. A similar MAIT cell impairement has been described in patients with chronic infections due to a primary immunodeficiency\[[@pntd.0006154.ref022]\].

In this study, we investigated MAIT cells response in *Flavivirus* infection. We report that MAIT cells are activated in acute DENV infection and have a poor response to *in vitro* bacterial stimulation. We also report that MAIT cells can produce IFNγ in response to *in vitro* ZIKV infection. This response was dependent on IL-12 and IL-18 and was impaired in HIV-1-infected individuals.

Materials and methods {#sec002}
=====================

Ethics statement {#sec003}
----------------

25 DENV-infected individuals from Sao Paulo, Brazil, were enrolled in the study (9 males and 16 females, age 17 to 87, [Table 1](#pntd.0006154.t001){ref-type="table"}). Patients were diagnosed with DENV infection by detection of DENV NS1 antigen and/or IgM-specific antibodies using a commercially available rapid test (Dengue Duo Test Bioeasy, Standard Diagnostic Inc. 575--34, Korea) or by detection of DENV RNA by real time PCR (RT-PCR). Absolute cell counts were determined using an automated hematology analyzer (Abbott Cell-Dyn 3700 Hematology Analyzer) at the Hematology Laboratory, Hematology Service, at the Faculty of Medicine, University of Sao Paulo. The study was approved by the University of Sao Paulo institutional review board (CAPPesq), and written informed consent was provided by all participants according to the Declaration of Helsinki. Buffy coats from healthy donors were obtained from the New York Blood Bank as approved by the George Washington University institutional review board. Samples from HIV-1-infected patients were obtained from the Jacobi Medical Center (NY, USA) and written informed consent was provided by all participants. This study was approved by Jacobi Medical Center and the George Washington University institutional review boards. All samples from all sites were anonymized. Minors were enrolled in the study, in which case legal guardians provided written informed consent according to the Declaration of Helsinki.

10.1371/journal.pntd.0006154.t001

###### DENV patient demographics and cell count.

![](pntd.0006154.t001){#pntd.0006154.t001g}

  DENV subject   Gender   Age   Leucocytes (cells/μL)   Neutrophiles (cells/μL)   Lymphocytes (cells/μL)   Monocytes (cells/μL)                        
  -------------- -------- ----- ----------------------- ------------------------- ------------------------ ---------------------- ------ ------ ------ ------
  1              M        28    3500                    4800                      1120                     29820                  1750   1200   460    380
  2              F        25    2330                    2300                      700                      3380                   1170   2520   300    130
  3              M        36    ND                      ND                        ND                       ND                     ND     ND     ND     ND
  4              M        36    4640                    6470                      1810                     3170                   1900   2650   460    580
  5              M        30    3280                    7060                      1020                     3530                   1640   2540   390    490
  6              F        41    4080                    8430                      1960                     5050                   1630   2440   450    590
  7              F        28    4280                    7460                      2090                     4700                   1670   1940   430    600
  8              F        31    5610                    8850                      3870                     6990                   1180   1240   450    620
  9              F        33    6180                    5910                      3710                     5820                   1790   2030   250    700
  10             F        38    2460                    7750                      950                      2840                   1230   2190   150    710
  11             M        59    5930                    5290                      2190                     3640                   2610   2940   800    1010
  12             F        63    4510                    6700                      500                      2060                   3340   2330   360    580
  13             F        64    4909                    5950                      1350                     3750                   2540   1880   900    940
  14             F        17    4260                    7020                      1830                     2800                   2000   2680   380    360
  15             F        35    2450                    7210                      830                      3090                   980    3090   510    700
  16             M        87    4880                    11840                     3270                     4830                   680    1370   930    940
  17             F        17    5570                    7150                      2510                     8290                   2010   1780   1000   1070
  18             M        21    7310                    4020                      5410                     4360                   800    2430   1100   290
  19             F        63    3130                    8000                      2160                     2060                   310    2330   630    580
  20             F        76    2480                    5630                      1530                     2490                   600    1170   320    320
  21             F        36    2700                    8030                      1270                     4240                   920    3120   490    480
  22             M        47    3820                    5630                      2410                     2540                   1150   2310   530    560
  23             F        42    2710                    8030                      1080                     5380                   1270   2090   250    480
  24             F        66    4110                    9300                      2670                     5670                   820    2980   580    470
  25             M        40    4030                    7940                      1890                     5960                   1590   1590   480    240

ND: not determined. Normal range (cells/μl); Leukocytes: 4000--11000; Neutrophils 1600--7000; Lymphocytes: 900--3400; Monocytes 200--900.

Sample collection {#sec004}
-----------------

Peripheral blood mononuclear cells (PBMCs) were isolated by density-gradient sedimentation using Ficoll-Paque (Lymphoprep, Nycomed Pharma, Oslo, Norway). Isolated PBMCs were washed twice in Hank's balanced salt solution (Gibco, Grand Island, NY), and cryopreserved in RPMI 1640 (Gibco), supplemented with 20% heat inactivated fetal bovine serum (FBS; Hyclone Laboratories, Logan UT), 50 U/ml of penicillin (Gibco), 50 μg/ml of streptomycin (Gibco), 10 mM glutamine (Gibco) and 7.5% dimethylsulphoxide (DMSO; Sigma, St Louis, MO). Cryopreserved cells from all subjects were stored in liquid nitrogen until used in the assays. For DENV-infected patients, samples were collected during the acute phase of infection (before defervescence) and 1 month after (convalescent phase). Plasma was collected by centrifugation and stored at -80°C until used in the assays.

ZIKV stock preparation {#sec005}
----------------------

Vero cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and maintained using Eagle's Minimum Essential Medium (ATCC) supplemented with 10% fetal bovine serum (FBS) at 37°C with 5% CO~2~. ZIKV MR766 (ATCC) was added to Vero cells at a MOI of 0.1 and incubated for 4--6 days. The supernatant was centrifuged at 12 000*g* for 5 min, filtered (0.44 μm), aliquoted and stored at --80°C. The viral titer was determined using plaque assays on Vero cells as previously described\[[@pntd.0006154.ref023]\]. Briefly, virus stocks were serially diluted and adsorbed to confluent monolayers. After 1 h, the inoculum was removed and cells were overlaid with semisolid medium containing 1% carboxymethyl cellulose (Sigma Aldrich, St-Louis, MO, USA). Cells were further incubated for 5 days, fixed in 4% formaldehyde (Sigma Aldrich), and stained with 1% crystal violet in 20% ethanol (Sigma Aldrich) for plaque visualization. Titers were expressed as plaque forming units (PFU) per milliliter. In some experiments, ZIKV was heat inactivated by a 60 minutes incubation at 56°C.

Flow cytometry and mAbs {#sec006}
-----------------------

Cryopreserved specimens were thawed and washed, and counts and viability were assessed using the Countess Automated Cell Counter system (Invitrogen, Carlsbad, CA). Cells were washed and stained in Brilliant Violet Stain Buffer (BD Biosciences, San Jose, CA) at room temperature for 15 min in 96-well V-bottom plates in the dark. Samples were then washed and fixed using Cytofix/Cytoperm (BD Biosciences) before flow cytometry data acquisition. Intracellular staining was performed in Perm/Wash (BD Biosciences). mAbs used in flow cytometry: CD3 AF700, CD3 PerCP-Cy5.5 (both clone UCHT1), CD8 BV711 (clone RPA-T8), CD38 APC-H7 (clone HB7), CD127 FITC (clone HIL-7R-M2), CD161 BV421 (clone DX12), CCR6 BV786 (clone 11A9), HLA-DR APC (clone L243), IFNγ APC (clone B27), and PD-1 PE-Cy7 (clone EH12.1) were all from BD Biosciences, PLZF APC was from R&D Systems (Minneapolis, MN), EOMES FITC (clone WD1928) was from eBioscience and TCR Vα7.2 PE (clone 3C10) was from Biolegend (San Diego, CA, USA). Live/dead aqua fixable cell stain was from Life Technologies (Eugene, OR, USA). Data were acquired on a BD LSRFortessa instrument (BD Biosciences) and analyzed using FlowJo Version 9.8.5 software (TreeStar, Ashland, OR, USA).

Functional assay {#sec007}
----------------

MAIT cell function was determined *in vitro* using paraformaldehyde-fixed *E*. *coli* stimulation (one shot top10, Life Technology, multiplicity of exposure 10) in the presence of 1.25 μg/ml anti-CD28 mAb (clone L293, BD Biosciences)\[[@pntd.0006154.ref024]\] or ZIKV at a MOI of 5 (without anti CD28 mAb). *E*. *coli* was fixed for 5 minutes in 1% paraformaldehyde. PBMCs were further cultured for 24 hours at 37°C/5% CO~2~ in RPMI medium supplemented with 10% fetal bovin serum. Monensin (Golgi Stop, BD Biosciences) was added during the last 6 hours of the stimulation. In some experiments blocking antibodies against MR-1 (5μg/ml, clone 26.5, Biolegend), IL-12p70 (10μg/ml, clone 24910, R&D systems), and IL-18 (10μg/ml, clone 125-2H, MBL International, Woburn, MA, USA) were added.

IL-7 and soluble CD14 (sCD14) measurement {#sec008}
-----------------------------------------

IL-7 (RayBiotech, Norcross, GA, USA) and sCD14 (R&D Systems) were measured in plasma by ELISA following manufacturer's instruction.

Statistical analysis {#sec009}
--------------------

All statistical analysis was performed using Graph Pad Prism version 6.0h for Mac OSX (GraphPad Software, La Jolla, CA). The changes between acute and convalescent phases and before/after ZIKV stimulation with or without blocking antibodies were analyzed with Wilcoxon matched-pairs signed rank test. Associations between groups were determined by Spearman\'s rank correlation. P-values ≤ 0.05 were considered statistically significant.

Results {#sec010}
=======

We enrolled 25 individuals with acute DENV infection, and we followed them during the convalescent phase ([Table 1](#pntd.0006154.t001){ref-type="table"}). We evaluated MAIT cell (defined as CD3+ CD161+ Vα7.2+, [Fig 1A](#pntd.0006154.g001){ref-type="fig"}) frequency by flow cytometry and found no significant difference between acute and convalescent DENV infection ([Fig 1B](#pntd.0006154.g001){ref-type="fig"}). However, MAIT cell counts were decreased in the acute phase ([Fig 1C](#pntd.0006154.g001){ref-type="fig"}) due to significant overall lymphopenia amongst infected patients ([S1 Fig](#pntd.0006154.s001){ref-type="supplementary-material"}). Next, we characterized the phenotype of MAIT cells in the acute and convalescent phases of DENV infection. MAIT cells had significantly increased co-expression of the activation markers CD38 and HLA-DR ([S1 Fig](#pntd.0006154.s001){ref-type="supplementary-material"} and [Fig 1D](#pntd.0006154.g001){ref-type="fig"}), of the IL-7 receptor CD127 ([S1 Fig](#pntd.0006154.s001){ref-type="supplementary-material"} and [Fig 1E](#pntd.0006154.g001){ref-type="fig"}), and of PD-1 ([S1 Fig](#pntd.0006154.s001){ref-type="supplementary-material"} and [Fig 1F](#pntd.0006154.g001){ref-type="fig"}) in the acute phase. We did not observe any difference in the expression of CCR6 by MAIT between the acute and convalescent phases ([Fig 1G](#pntd.0006154.g001){ref-type="fig"}). In chronic viral infections MAIT cell activation is associated with their reduced frequency\[[@pntd.0006154.ref019], [@pntd.0006154.ref021]\]. Thus, we investigated if there was an association between the reduced MAIT cell count in the acute phase and their increased co-expression of CD38 and HLA-DR, and found a trend for an inverse association (p = 0.0779, [S1 Fig](#pntd.0006154.s001){ref-type="supplementary-material"}). Next, we compared the results for MAIT cells during the convalescent phase to healthy controls from Brazil. We found that there was no difference in the co-expression of CD38 and HLA-DR between the convalescent and healthy controls individuals ([S2 Fig](#pntd.0006154.s002){ref-type="supplementary-material"}). PD-1 remained elevated during the convalescent phase of DENV infection ([S2 Fig](#pntd.0006154.s002){ref-type="supplementary-material"}) and CD127 was decreased compared to healthy controls ([S2 Fig](#pntd.0006154.s002){ref-type="supplementary-material"}). Our results show that MAIT cells are activated and reduced in number in acute DENV infection.

![MAIT cells have elevated expression of activation markers in acute DENV infection.\
Gating strategy and representative flow plots of MAIT cell frequency (A). MAIT cell frequency in acute and convalescent DENV infection (n = 25, B). MAIT cell count, (as determined by multiplying the lymphocyte count by the frequency of MAIT cells in lymphocytes), in acute and convalescent DENV infection (n = 24, C). Co-expression of CD38 and HLA-DR by MAIT cells in acute and convalescent DENV infection (n = 15, D). CD127 expression (MFI) by MAIT cells in acute and convalescent DENV infection (n = 15, E). PD-1 expression by MAIT cells in acute and convalescent DENV infection (n = 15, F). CCR6 expression (MFI) by MAIT cells in acute and convalescent DENV infection (n = 15, G). \*\* indicates p \< 0.01, and \*\*\* indicates p \< 0.001.](pntd.0006154.g001){#pntd.0006154.g001}

Because the majority of MAIT cells are CD8+, we evaluated the response of conventional CD8 T cells in acute DENV infection. Conventional CD8 T cells had significantly elevated levels of co-expression of CD38 and HLA-DR in the acute phase and the levels of co-expression in the convalescent phase were similar to healthy controls ([S3 Fig](#pntd.0006154.s003){ref-type="supplementary-material"}). PD-1 was also elevated on CD8 T cell in the acute phase of infection. However, PD-1 levels in the convalescent phase trend to remain elevated compared to healthy controls ([S3 Fig](#pntd.0006154.s003){ref-type="supplementary-material"}). However, in contrast to MAIT cells, the levels of CD127 on conventional CD8 T cells were not different between the acute and the convalescent phase, or healthy controls ([S3 Fig](#pntd.0006154.s003){ref-type="supplementary-material"}).

MAIT cells have been shown to have decreased expression of key transcription factors in chronic viral infections\[[@pntd.0006154.ref021], [@pntd.0006154.ref025], [@pntd.0006154.ref026]\]. Therefore, we investigated if MAIT cells showed a similar decrease of Eomes and PLZF expression in acute DENV infection. We found that Eomes expression was reduced in convalescent DENV infection ([Fig 2A and 2B](#pntd.0006154.g002){ref-type="fig"}) compared to the acute phase and healthy controls. However, we did not observe any difference in PLZF expression between acute and convalescent DENV infection or healthy controls ([Fig 2A and 2C](#pntd.0006154.g002){ref-type="fig"}). Our results suggest that different transcription factor expression profiles are associated with acute and chronic viral infections respectively.

![Reduced Eomes expression by MAIT cells in convalescent DENV infection.\
Representative flow plots for Eomes and PLZF expression by MAIT cells (A). Eomes (B) and PLZF (C) expression (MFI) by MAIT cells in acute and convalescent DENV infection (n = 12) and healthy control (n = 6). The bars and whiskers represent the median and interquartile range respectively. \* indicates p \< 0.05.](pntd.0006154.g002){#pntd.0006154.g002}

Increased pro-inflammatory cytokines levels in DENV infection have been associated with microbial translocation\[[@pntd.0006154.ref027]\]. sCD14 is a marker of monocyte activation and is considered an indirect marker of microbial translocation\[[@pntd.0006154.ref028]\]. Thus, we measured the levels of sCD14 in our cohort of DENV-infected subjects. Levels of sCD14 were significantly higher in the acute phase of infection than in the convalescent phase ([Fig 3A](#pntd.0006154.g003){ref-type="fig"}). Levels of sCD14 remained higher in convalescent DENV compared to healthy controls. However, we did not find any significant associations between the levels of sCD14 in acute DENV infection and co-expression of CD38 and HLA-DR by MAIT cells or with MAIT cell numbers ([S4 Fig](#pntd.0006154.s004){ref-type="supplementary-material"}). Because we found elevated expression of the IL-7 receptor by MAIT cells in acute DENV infection, we measured the levels of plasma IL-7 in acute and convalescent DENV infection but did not find any significant change ([Fig 3B](#pntd.0006154.g003){ref-type="fig"}).

![Increased levels of sCD14 in acute DENV infection.\
Plasma levels of sCD14 (A) and IL-7 (B) in acute and convalescent DENV infection were determined for subjects 1--10 (n = 10) and for healthy control (n = 5). The bars and whiskers represent the median and interquartile range respectively. \*\* indicates p \< 0.01.](pntd.0006154.g003){#pntd.0006154.g003}

Next, to establish the functionality of MAIT cells, we investigated the *in vitro* response of MAIT cells from the acute and convalescent phases of DENV infection to *in vitro* stimulation with *E*. *coli*. There was no difference in IFNγ production by MAIT cells in the acute and convalescent phases of DENV infection in the absence of stimulation ([S5 Fig](#pntd.0006154.s005){ref-type="supplementary-material"}). MAIT cells in the acute phase produced significantly less IFNγ after *E*. *coli* stimulation compared to the convalescent phase ([Fig 4A and 4B](#pntd.0006154.g004){ref-type="fig"}). The MAIT cell IFNγ response in the convalescent phase was similar to the response of healthy controls ([S5 Fig](#pntd.0006154.s005){ref-type="supplementary-material"}). Interestingly, we found that the levels of sCD14 in acute DENV infection were inversely associated with the MAIT cell IFNγ response ([Fig 4C](#pntd.0006154.g004){ref-type="fig"}), possibly suggesting a role for monocyte activation in the poor MAIT cell response.

![Lower IFNγ production following *in vitro* stimulation with *E*. *coli* by MAIT cells in acute DENV infection.\
MAIT cells were stimulated with fixed *E*. *coli* (multiplicity of exposure 10) for 24h and IFNγ production by MAIT cells was evaluated by flow cytometry. Representative flow plots of IFNγ production by MAIT cells (A). IFNγ production by MAIT cells in response to *E*. *coli* stimulation in acute and convalescent DENV infection (n = 15, B). Association between the levels of sCD14 and MAIT cells IFNγ response to *E*. *coli* stimulation in acute DENV infection (C). \* indicates p \< 0.05.](pntd.0006154.g004){#pntd.0006154.g004}

Finally, we used *in vitro* infection with ZIKV to study the mechanism of MAIT cell activation in a different *Flavivirus* infection. MAIT cells from healthy individuals consistently produced IFNγ in response to *in vitro* ZIKV infection ([Fig 5A and 5B](#pntd.0006154.g005){ref-type="fig"}). In contrast to *E*. *coli*, the MAIT cell IFNγ response to ZIKV could not be blocked by a MR-1 blocking antibody ([Fig 5C](#pntd.0006154.g005){ref-type="fig"}). The IFNγ response from MAIT cells to ZIKV was partially reduced by blocking antibodies against IL-12 and IL-18 and was completely blocked when they were used in combination ([Fig 5C](#pntd.0006154.g005){ref-type="fig"}). We also investigated if viral replication was needed for the MAIT cell response to *in vitro* ZIKV infection. For this purpose, heat inactivated ZIKV was added to PBMCs and the MAIT cell IFNγ response was compared to the response obtained using replication competent ZIKV. We observed only a small reduction in IFNγ production by MAIT cells in response to ZIKV when using a heat inactivated virus ([Fig 5C](#pntd.0006154.g005){ref-type="fig"}), suggesting that viral replication is not needed for production of IL-12 and IL-18 and subsequent MAIT cell activation.

![MAIT cells response to *in vitro* ZIKV infection is dependent on IL-12 and IL-18.\
PBMCs were infected with ZIKV (MOI: 5) for 24h and IFNγ production by MAIT cells was evaluated by flow cytometry. Representative flow plots of IFNγ production by MAIT cells (A). MAIT cells IFNγ response to ZIKV infection (n = 9, B). PBMCs were incubated in presence of MR1 (n = 6), IL-12 (n = 4), IL-18 (n = 8), and IL-12 + IL-18 (n = 4) blocking antibodies and stimulated with *E*. *coli*, ZIKV, or heat inactivated ZIKV (n = 4) and IFNγ production by MAIT cells was measured (C). The results are presented as relative production of IFNγ by MAIT cells compared to the condition without any blocking antibody. Statistical analysis was performed before data normalization. PBMCs from HIV-1- (n = 8) and HIV-1+ (n = 6) subjects were infected with ZIKV (MOI: 5) and IFNγ production by MAIT cell was evaluated (D). PBMCs from HIV-1- (n = 6) and HIV-1+ (n = 6) subjects were treated with IL-12 and IL-18 (both at 50ng/ml) for 24 hours and IFNγ production by MAIT cell was evaluated (E). The bars and whiskers represent the median and interquartile range respectively. \* indicates p \< 0.05 and \*\* indicates p \< 0.01.](pntd.0006154.g005){#pntd.0006154.g005}

Viral co-infections are common and understudied. In Brazil, many people living with HIV will be exposed to dengue or zika viruses. MAIT cells from HIV-1-infected individuals exhibit decreased functionality following stimulation with *E*. *coli*\[[@pntd.0006154.ref019]\]. Thus, we evaluated the capacity of MAIT cells from HIV-1-infected subjects ([Table 2](#pntd.0006154.t002){ref-type="table"}) to produce IFNγ in response to ZIKV infection and found that in 5 out of 6 individuals there was no increase in IFNγ production in response to ZIKV infection ([Fig 5D](#pntd.0006154.g005){ref-type="fig"}). We then directly stimulated PBMCs with IL-12 and IL-18 and found a similar IFNγ response by MAIT cells from HIV-1-infected and uninfected subjects ([Fig 5E](#pntd.0006154.g005){ref-type="fig"}), suggesting that MAIT cells from HIV-1-infected individuals have a normal capacity to respond to cytokine stimulation.

10.1371/journal.pntd.0006154.t002

###### HIV-1 patients demographics and characteristics.

![](pntd.0006154.t002){#pntd.0006154.t002g}

  HIV Subject   Gender   Age    Treatment   Comment
  ------------- -------- ------ ----------- ------------------------------
  1             M        15.2   Yes         
  2             F        17.2   Yes         Variable treatment adherence
  3             F        17.8   Yes         
  4             M        26.8   Yes         
  5             M        25.0   No          Non progressor
  6             M        18.8   Yes         

Discussion {#sec011}
==========

We found that MAIT cells are activated in acute human DENV infection as well as following *in vitro* ZIKV infection. However, in contrast to a previous study\[[@pntd.0006154.ref017]\], we did not find any significant changes in MAIT cell frequency between acute and convalescent DENV infection. Wilgenburg *et al*. focused on the study of CD8+ MAIT cells, while in this study, we also included CD8- MAIT cells. In addition, the difference in timing of sample collection might explain the differences between the two studies. We found that MAIT cell counts were decreased in parallel with the total lymphocyte count during the acute phase. We found that MAIT cells were activated during acute DENV infection, as had Wilgenburg and colleagues. IL-12 and IL-18 have been shown to trigger MAIT cell activation\[[@pntd.0006154.ref016]\], and monocyte production of IL-18 is required for MAIT cell *in vitro* response to influenza A virus (IAV)\[[@pntd.0006154.ref018]\]. The levels of IL-12 and IL-18 are elevated in DENV infection\[[@pntd.0006154.ref017], [@pntd.0006154.ref029]--[@pntd.0006154.ref031]\] and could therefore be involved in MAIT cell activation, as shown here. We showed that MAIT cell IFNγ production following *in vitro* ZIKV infection also depended on IL-12 and IL-18. Immune activation in acute DENV infection has been associated with elevated levels of LPS and of markers of microbial translocation\[[@pntd.0006154.ref027], [@pntd.0006154.ref032]\]. This raises the possibility that MAIT cells could also be activated in a TCR-dependent way by microbial products during acute DENV. However, we did not find an association between the levels of sCD14, an indirect marker of microbial translocation, and MAIT cell activation in acute DENV. Rather, we found that sCD14 was inversely associated with the *in vitro* IFNγ response of MAIT cells to *E*. *coli*. This suggests that monocyte activation could result in poor antigen presentation to MAIT cells. An alternative explanation could be of a temporary monocyte tolerance to stimulation induced by LPS. This could contribute to the reduced MAIT cell response in the acute phase. Finally, the elevated expression of PD-1 on MAIT cells during acute DENV infection could also contribute to the reduced IFNγ production. Further studies are needed to confirm that both MAIT cells and monocytes are involved in this defect.

Chronic viral infections have been associated with a reduced expression of the transcription factors PLZF and Eomes by MAIT cells\[[@pntd.0006154.ref021], [@pntd.0006154.ref025], [@pntd.0006154.ref026]\]. Interestingly, we found that DENV infection did not change the levels of PLZF expression in MAIT cells and their Eomes levels were reduced in convalescent compared to acute DENV and healthy controls. CD56+ MAIT cells have been shown to have a higher Eomes expression and a more robust response to IL-12 and IL-18 than CD56- MAIT cells \[[@pntd.0006154.ref011]\]. Therefore, it is possible that the decrease in Eomes expression by MAIT cells in convalescent DENV infection is part of a feedback loop to decrease their response to cytokines. Another possibility is a decrease in the CD56+ subset of MAIT cells in blood following acute DENV. We have also observed a decreased expression of the IL-7 receptor (CD127) by MAIT cells during the convalescent phase. IL-7 has been shown to increase MAIT cell response\[[@pntd.0006154.ref026], [@pntd.0006154.ref033]\]. Thus, reduced levels of Eomes and CD127 could by a mechanism by which MAIT cells could prevent sustained activation following an acute infection.

Patients that recovered from IAV infection had higher circulating MAIT cells than those that succumbed\[[@pntd.0006154.ref018]\] and IFNγ production by MAIT cells has been shown to limit HCV replication *in vitro\[[@pntd.0006154.ref017]\]*. Thus, there is increasing evidence that MAIT cells could play a protective role in viral infections. DENV and ZIKV infections are associated with a range of clinical symptoms. More studies are needed to investigate if MAIT cell frequency, functionality or activation status have an impact on the clinical outcome of DENV and ZIKV infections. In this regard, MAIT cell production of IFNγ could be part of an innate immune response to induce an anti-viral state and compromise *Flavivirus* replication. Levels of serum IFNγ have been reported to be inversely associated with DENV load and symptoms\[[@pntd.0006154.ref034]\]. One limitation of our study is that we focused only on peripheral MAIT cells. MAIT cells are present in the skin\[[@pntd.0006154.ref035], [@pntd.0006154.ref036]\] and skin resident MAIT cells may play a more important role in early innate defense following mosquito transmission of *Flavivirus*.

MAIT cells from HIV-1-infected individuals have been shown to have a lower production of cytokines in response to *E*. *coli* stimulation\[[@pntd.0006154.ref019]\]. In this study, we show that the cytokine mediated MAIT cell response to *in vitro* viral infection is also impaired. However, MAIT cells from HIV-1-infected subjects had a normal response to direct cytokine stimulation, suggesting that poor IL-12 and IL-18 production in response to ZIKV infection could be responsible for the impaired MAIT cell response in these individuals. This suggests that HIV-1-infected individuals could have a poor innate immune response to ZIKV and be at a higher risk to develop complications following *Flavivirus* infection. Case reports of HIV-1-infected individuals with ZIKV infection have been reported\[[@pntd.0006154.ref037], [@pntd.0006154.ref038]\], including one case with congenital Zika syndrome\[[@pntd.0006154.ref039]\]. Defective MAIT cell activation could be one factor contributing to the increase incidence of severe dengue in HIV-1-infected subjects\[[@pntd.0006154.ref040]\]. More studies are needed to determine if MAIT cells contribute to protection or to immunopathology during *Flavivirus* infections.

Overall, our results show that MAIT cells are activated in response to DENV and ZIKV infections. This innate response was TCR-independent and defective in HIV-1-infected individuals. Further studies are necessary to determine the importance of MAIT cell responses in the clinical outcomes of *Flavivirus* infections.

Supporting information {#sec012}
======================
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Lymphocytes count in acute and convalescent DENV infection (n = 24, A). Representative flow plots of CD38 and HLA-DR co-expression by MAIT cells in acute and convalescent DENV infection (B). CD127 expression level by MAIT cells in acute and convalescent DENV infection (C). Representative flow plots of PD-1 expression by MAIT cells in acute and convalescent DENV infection (D). Association between CD38 and HLA-DR co-expression and MAIT cells count in acute DENV infection (E).
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Click here for additional data file.
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MAIT cell frequency in convalescent DENV infection (n = 25) and healthy controls (n = 26), (A). Co-expression of CD38 and HLA-DR by MAIT cells in convalescent DENV infection (n = 15) and healthy controls (n = 26), (B). PD-1 expression by MAIT cells in convalescent DENV infection (n = 15) and healthy controls (n = 26), (C). CD127 expression (MFI) by MAIT cells in convalescent DENV infection (n = 15) and healthy controls (n = 7), (D). \* indicates p \< 0.05, and \*\* indicates p \< 0.01.
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Co-expression of CD38 and HLA-DR by conventional CD8 T cells (excluding MAIT cells) during acute and convalescent DENV infection (n = 10) and healthy controls (n = 23) (A). PD-1 expression by conventional CD8 T cells in acute and convalescent DENV infection (n = 10) and healthy controls (n = 23) (B). CD127 expression by convetional CD8 T cells in acute and convalescent DENV infection (n = 10) and healthy controls (n = 5) (C). The bars and whiskers represent the median and interquartile range, respectively. \* indicates p \< 0.05 and \*\* indicates p \< 0.01.
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Associations between sCD14 levels and co-expression of CD38 and HLA-DR by MAIT cells (A) and MAIT cell count (B) in acute DENV infection.
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Representative flow plots showing IFNγ production by unstimulated MAIT cells in acute and convalescent dengue infection (A). IFNγ production by unstimulated MAIT cells in acute and convalescent dengue infection (n = 12, B). IFNγ production by *E*. *coli* stimulated MAIT cells in convalescent dengue infection (n = 15) and control subjects (n = 10) (C). The bars and whiskers represent the median and interquartile range, respectively.
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